![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/277 | |
A61K 31/198 | |||
A61K 45/06 | |||
A61P 25/16 | |||
A61K 9/20 | |||
A61K 9/28 |
(11) | Number of the document | 2542220 |
(13) | Kind of document | T |
(96) | European patent application number | 11709446.6 |
Date of filing the European patent application | 2011-03-03 | |
(97) | Date of publication of the European application | 2013-01-09 |
(45) | Date of publication and mention of the grant of the patent | 2016-11-02 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/FI2011/000013 |
Date | 2011-03-03 |
(87) | Number | WO 2011/107653 |
Date | 2011-09-09 |
(30) | Number | Date | Country code |
438416 P | 2011-02-01 | US | |
412821 P | 2010-11-12 | US | |
310398 P | 2010-03-04 | US |
(72) |
ROURU, Juha, FI
KUOPPAMÄKI, Mikko, FI
ELLMEN, Juha, FI
MÄNNISTÖ, Pekka, FI
|
(73) |
Orion Corporation,
Orionintie 1, 02200 Espoo,
FI
|
(54) | USE OF LEVODOPA, CARBIDOPA AND ENTACAPONE FOR TREATING PARKINSON`S DISEASE |
USE OF LEVODOPA, CARBIDOPA AND ENTACAPONE FOR TREATING PARKINSON`S DISEASE |